Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-026452
Filing Date
2017-05-11
Accepted
2017-05-11 16:12:57
Documents
69
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v465720_10q.htm 10-Q 495134
2 EXHIBIT 10.1 v465720_ex10-1.htm EX-10.1 167805
3 EXHIBIT 31.1 v465720_ex31-1.htm EX-31.1 9864
4 EXHIBIT 31.2 v465720_ex31-2.htm EX-31.2 9905
5 EXHIBIT 32.1 v465720_ex32-1.htm EX-32.1 4691
  Complete submission text file 0001144204-17-026452.txt   5803565

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aytu-20170331.xml EX-101.INS 1170747
7 XBRL TAXONOMY EXTENSION SCHEMA aytu-20170331.xsd EX-101.SCH 62477
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aytu-20170331_cal.xml EX-101.CAL 51347
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aytu-20170331_def.xml EX-101.DEF 430864
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aytu-20170331_lab.xml EX-101.LAB 438315
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aytu-20170331_pre.xml EX-101.PRE 465856
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-53121 | Film No.: 17834428
SIC: 2834 Pharmaceutical Preparations